138 related articles for article (PubMed ID: 3046484)
21. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
Parish LC; Aten EM
Cutis; 1984 Dec; 34(6):567-70. PubMed ID: 6394217
[TBL] [Abstract][Full Text] [Related]
22. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial.
Pallin DJ; Binder WD; Allen MB; Lederman M; Parmar S; Filbin MR; Hooper DC; Camargo CA
Clin Infect Dis; 2013 Jun; 56(12):1754-62. PubMed ID: 23457080
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of two dosage schedules of cephalexin in dermatologic infections.
DiMattia AF; Sexton MJ; Smialowicz CR; Knapp WH
J Fam Pract; 1981 Apr; 12(4):649-52. PubMed ID: 7205167
[TBL] [Abstract][Full Text] [Related]
24. [Comparative clinical study of DL-8280 and cefaclor for suppurative skin and soft tissue infections by a double-blind method].
Fujita K; Nakano M; Nonami E; Shishiba T; Katsumata M; Horie N; Watanabe R; Kukita A; Watanabe S; Someya T
Kansenshogaku Zasshi; 1984 Sep; 58(9):793-819. PubMed ID: 6440917
[No Abstract] [Full Text] [Related]
25. Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.
Pien FD
Antimicrob Agents Chemother; 1983 Dec; 24(6):856-9. PubMed ID: 6362559
[TBL] [Abstract][Full Text] [Related]
26. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.
Rajendran PM; Young D; Maurer T; Chambers H; Perdreau-Remington F; Ro P; Harris H
Antimicrob Agents Chemother; 2007 Nov; 51(11):4044-8. PubMed ID: 17846141
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of sustained release cephalexin (S-6436, S-6437) in dermatology (author's transl)].
Okita K; Sato M; Hayakawa K; Kimura K
Jpn J Antibiot; 1977 Nov; 30(11):911-5. PubMed ID: 592493
[TBL] [Abstract][Full Text] [Related]
28. Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study Group.
Linder CW; Nelson K; Paryani S; Stallworth JR; Blumer JL
Clin Ther; 1993; 15(1):46-56. PubMed ID: 8458054
[TBL] [Abstract][Full Text] [Related]
29. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cefonicid and cefazolin for treatment of soft-tissue infections.
Slutkin G; Marzouk J; Dall L; Mills J
Rev Infect Dis; 1984; 6 Suppl 4():S853-6. PubMed ID: 6395276
[TBL] [Abstract][Full Text] [Related]
31. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
Ballantyne FN
Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
[TBL] [Abstract][Full Text] [Related]
33. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
[TBL] [Abstract][Full Text] [Related]
34. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.
Parish LC; Routh HB; Miskin B; Fidelholtz J; Werschler P; Heyd A; Haverstock D; Church D
Int J Clin Pract; 2000 Oct; 54(8):497-503. PubMed ID: 11198726
[TBL] [Abstract][Full Text] [Related]
35. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.
Menday AP
Int J Antimicrob Agents; 2000 Jan; 13(3):183-7. PubMed ID: 10724022
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of cephradine, a new oral cephalosporin.
Scholand JF; Hodges GR; Fass RJ; Saslaw S
Am J Med Sci; 1974 Feb; 267(2):111-6. PubMed ID: 4595266
[No Abstract] [Full Text] [Related]
37. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
[TBL] [Abstract][Full Text] [Related]
38. Addition of rifampin to cephalexin therapy for recalcitrant staphylococcal skin infections--an observation.
Feder HM; Pond KE
Clin Pediatr (Phila); 1996 Apr; 35(4):205-8. PubMed ID: 8665754
[TBL] [Abstract][Full Text] [Related]
39. Treatment of skin and soft tissue infections: a comparative study of cefmetazole and cefoxitin.
Frank E; Phillips SL; Gupta T; Bavishi N; Casey KK
J Antimicrob Chemother; 1989 Apr; 23 Suppl D():55-60. PubMed ID: 2722724
[TBL] [Abstract][Full Text] [Related]
40. Therapy of infections with parenteral cephalexin.
Solberg CO; Schreiner A; Hamre E; Digranes A
Chemotherapy; 1973 Oct; 19(4):215-20. PubMed ID: 4149295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
